High-sensitivity C-reactive protein is not independently associated with peripheral subclinical atherosclerosis

Mario Bo1, Laura Corsinovi, Alessia Brescianini

  • 1SCDU Geriatria, Dipartimento di Discipline Medico Chirurgiche, Azienda Sanitaria San Giovanni Battista, Corso Bramante 88, Turin, Italy. mario.bo@unito.it

Angiology
|October 9, 2008
PubMed

Insights

High-sensitivity C-reactive protein (hs-CRP) is linked to peripheral atherosclerosis severity in at-risk individuals. However, this association is not independent of traditional cardiovascular risk factors.

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Atherosclerosis Research

Background:

  • High-sensitivity C-reactive protein (hs-CRP) is a marker of inflammation.
  • Subclinical peripheral atherosclerosis involves early arterial changes.
  • The independent predictive value of hs-CRP for atherosclerosis requires further investigation.

Purpose of the Study:

  • To determine if hs-CRP levels are independently associated with subclinical peripheral atherosclerosis.
  • To evaluate the relationship between hs-CRP and measures of atherosclerosis like ABI and cIMT.

Main Methods:

  • A cohort of 320 subjects without prior cardiovascular disease was studied.
  • Clinical variables, cardiovascular risk factors, and 10-year CV risk were assessed.
  • Ankle-brachial Index (ABI) and carotid intima-media thickness (cIMT) were measured.

Main Results:

  • hs-CRP levels correlated with cardiovascular risk factors, 10-year CV risk, lower ABI, and higher cIMT.
  • After adjusting for covariates, hs-CRP associations with ABI and cIMT were not statistically significant.

Conclusions:

  • hs-CRP levels are associated with peripheral atherosclerosis severity in asymptomatic individuals.
  • These associations are not independent of traditional cardiovascular risk factors.
  • hs-CRP may have a limited independent predictive role for subclinical atherosclerosis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...